{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:16:16Z","timestamp":1785215776040,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["314730B_201266"],"award-info":[{"award-number":["314730B_201266"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.xpro.2024.103056","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T23:15:36Z","timestamp":1725059736000},"page":"103056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["ART-DEX: A novel strategy to monitor broadly neutralizing antibody activity during antiretroviral therapy of HIV-1"],"prefix":"10.1016","volume":"5","author":[{"given":"Magdalena","family":"Schwarzm\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-876X","authenticated-orcid":false,"given":"Alexandra","family":"Trkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2024.103056_bib1","doi-asserted-by":"crossref","unstructured":"Schwarzm\u00fcller, M., Schanz, M., Abela, I.A., Epp, S., Lozano, C., Curcio, M., Greshake, J., Rusert, P., Huber, M., Kouyos, R.D., et\u00a0al. Decoupling HIV-1 Antiretroviral Drug\u00a0Inhibition from Plasma Antibody Activity\u00a0to Evaluate Broadly Neutralizing Antibody Therapeutics and Vaccines. Cell Rep. Med. 5, 101702. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101702.","DOI":"10.1016\/j.xcrm.2024.101702"},{"key":"10.1016\/j.xpro.2024.103056_bib2","first-page":"147","article-title":"Optimization and Validation of a Neutralizing Antibody Assay for HIV-1 in TZM-bl Cells Using Luciferase Reporter Gen","volume":"409","author":"Montefiori","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.xpro.2024.103056_bib3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/nm.4187","article-title":"Determinants of HIV-1 broadly neutralizing ntibody induction","volume":"22","author":"Rusert","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xpro.2024.103056_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.virol.2006.11.004","article-title":"HIV-1 clones resistant to a small molecule\u00a0CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry","volume":"361","author":"Pugach","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.xpro.2024.103056_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1089\/088922203769232629","article-title":"Protein binding in\u00a0antiretroviral\u00a0therapies","volume":"19","author":"Boffito","year":"2003","journal-title":"AIDS Res.\u00a0Hum.\u00a0Retroviruses"}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166724002211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166724002211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T17:18:30Z","timestamp":1744996710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166724002211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2666166724002211"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2024.103056","relation":{},"ISSN":["2666-1667"],"issn-type":[{"value":"2666-1667","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ART-DEX: A novel strategy to monitor broadly neutralizing antibody activity during antiretroviral therapy of HIV-1","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2024.103056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103056"}}